In EAE and in a small proof-of-concept study, we characterized immune modulating consequences of UV light and were able to identify the critical relevance of two druggable receptors/transcription factors: melanocortin-1 receptor (MC-1R) and aryl hydrocarbon receptor (AhR) that are responsible for the beneficial effect of UV light. Moreover, we deduced the MC 1R ligand NDP-MSH as an environment mimetic and will now further develop NDP-MSH-containing microparticles towards a potential clinical application as an adjuvant therapeutic. Preclinical studies will be paralleled by investigations in MS patients as well as an exploratory intervention using UV-phototherapy.
| Wiendl, Heinz Siegfried |
| Wiendl, Heinz Siegfried |
Duration: 01/07/2016 - 31/12/2020 | 2nd Funding period Funded by: DFG - Collaborative Research Centre Type of project: Subproject in DFG-joint project hosted at University of Münster |
Duration: 01/01/2021 - 30/06/2024 | 3rd Funding period Funded by: DFG - Collaborative Research Centre Type of project: Main DFG-project hosted at University of Münster |